Promoting public awareness of MCT8 Deficiency, also known as Allan-Herndon-Dudley Syndrome (AHDS); Charitable services, namely, promoting public awareness of MCT8 Deficiency, also known as Allan-Herndon-Dudley Syndrome (AHDS); Promoting public awareness of MCT8 Deficiency, also known as Allan-Herndon-Dudley Syndrome (AHDS) by means of public advocacy; Promoting public interest and awareness of MCT8 Deficiency, also known as Allan-Herndon-Dudley Syndrome (AHDS)

Charitable foundation services, namely, providing financial support to families of patients with MCT8 Deficiency, also known as Allan-Herndon-Dudley Syndrome (AHDS) for equipment, therapies, and other needs; Charitable foundation services, namely, providing fundraising activities, funding, scholarships and/or financial assistance for families and patients living with MCT8 Deficiency, also known as Allan-Herndon-Dudley Syndrome (AHDS); Charitable fundraising services for promoting research, education and other activities relating to MCT8 Deficiency, also known as Allan-Herndon-Dudley Syndrome (AHDS); Charitable services in the nature of providing grants for families of patients with MCT8 Deficiency, also known as Allan-Herndon-Dudley Syndrome (AHDS)